* Axonics Inc AXNX.OQ AXNX.O is expected to show a rise
in
quarterly revenue when it reports results
* The Irvine California-based company is expected to report
a
27.5% increase in revenue to $89.73 million from $70.38 million
a year ago, according to the mean estimate from 13 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Axonics Inc is for
a loss
of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Axonics Inc
is
$75, above its last closing price of $49.38.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.10 -0.11 0.16 Beat 240.8
Mar. 31 2023 -0.28 -0.29 -0.19 Beat 33.9
Dec. 31 2022 -0.27 -0.24 0.01 Beat 104.1
Sep. 30 2022 -0.48 -0.48 -0.34 Beat 28.5
Jun. -0.54 -0.54 -0.47 Beat 13.4
30 2022
Mar. 31 2022 -0.65 -0.63 -0.50 Beat 21
Dec. 31 2021 -0.37 -0.37 -0.34 Beat 8.1
Sep. 30 2021 -0.43 -0.43 -0.38 Beat 11.9
This summary was machine generated October 28 at 01:49 GMT. All
figures in US dollars unless otherwise stated